Detalles de la búsqueda
1.
Differences in real-world outcomes by risk classification for localized prostate cancer patients after radiation therapy.
Prostate
; 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38685667
2.
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN.
Br J Cancer
; 130(1): 73-81, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37951974
3.
Development and Optimization of a Subtraction-Normalized Immunocyte Profiling Signature for Prostate Cancer Active Surveillance Risk Stratification.
J Urol
; 211(3): 415-425, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38147400
4.
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial.
J Urol
; 212(1): 74-86, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38704840
5.
Impact of darolutamide on local symptoms: pre-planned and post hoc analyses of the ARAMIS trial.
BJU Int
; 131(4): 452-460, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36087070
6.
A US real-world study of treatment patterns and outcomes in localized or locally advanced prostate cancer patients.
World J Urol
; 41(12): 3535-3542, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37966506
7.
Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial.
J Urol
; 207(1): 61-69, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34433303
8.
Plain language summary of the design of the TALAPRO-2 study comparing talazoparib and enzalutamide versus enzalutamide and placebo in men with metastatic castration-resistant prostate cancer.
Future Oncol
; 18(27): 2979-2986, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35950899
9.
Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 phase III study design.
Future Oncol
; 18(4): 425-436, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35080190
10.
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Lancet Oncol
; 22(1): 107-117, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33253641
11.
Longitudinal follow-up and performance validation of an mRNA-based urine test (Xpert® Bladder Cancer Monitor ) for surveillance in patients with non-muscle-invasive bladder cancer.
BJU Int
; 128(6): 713-721, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33793062
12.
Optimizing the management of castration-resistant prostate cancer patients: A practical guide for clinicians.
Prostate
; 80(14): 1159-1176, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32779781
13.
Development and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approach.
BMC Health Serv Res
; 20(1): 686, 2020 Jul 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32709234
14.
A Clinician's Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III).
J Urol
; 201(4): 682-692, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30077557
15.
Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET.
Future Oncol
; 14(6): 527-536, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29417827
16.
Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials.
BMC Urol
; 18(1): 77, 2018 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30189902
17.
Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials.
BMC Urol
; 18(1): 84, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30285696
18.
How I Do It: Hydrogel spacer placement in men scheduled to undergo prostate radiotherapy.
Can J Urol
; 25(2): 9288-9293, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29680009
19.
Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial.
JAMA
; 319(18): 1880-1888, 2018 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29801011
20.
Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study.
Cancer
; 123(15): 2850-2859, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28422278